Xilio Therapeutics XLO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 0.84 | 11.84 | -0.09 | -1,929 | -16 | |
| 2025Q2 | 0.68 | -0.16 | -14,366 | -16 | ||
| 2025Q1 | 0.72 | 104.42 | -0.18 | -13,851 | -13 | |
| 2024Q4 | 0.96 | 104.09 | -0.18 | -13,629 | -13 | |
| 2024Q3 | 0.79 | 105.29 | -0.18 | -14,762 | -14 | |
| 2024Q2 | 0.95 | 105.59 | -0.11 | -14,704 | -14 | |
| 2024Q1 | 1.08 | 101.65 | -0.62 | -17,487 | -17 | |
| 2023Q4 | 0.55 | 102.69 | -0.64 | -18,130 | -18 | |
| 2023Q3 | 2.11 | 103.66 | -0.61 | -17,361 | -17 | |
| 2023Q2 | 2.62 | 103.93 | -0.70 | -20,116 | -19 | |
| 2023Q1 | 3.17 | 103.89 | -0.83 | -23,526 | -23 | |
| 2022Q4 | 2.69 | 103.12 | -0.82 | -23,167 | -22 | |
| 2022Q3 | 2.91 | 102.10 | -0.72 | -20,206 | -20 | |
| 2022Q2 | 2.92 | 99.75 | -0.90 | -24,552 | -25 | |
| 2022Q1 | 7.07 | 99.40 | -0.78 | -21,224 | -21 | |
| 2021Q4 | 16.00 | 99.26 | 62.66 | -19,556 | -20 | |
| 2021Q3 | 98.22 | -21.02 | -15,961 | -16 | ||
| 2021Q2 | -23,007 | -23 | ||||
| 2021Q1 | -0.63 | -16,520 | -17 | |||
| 2020Q4 | -20,595 | -21 |